Approximately 618,918 units of Advil (ibuprofen) Tablets and Liqui-Gels have been recalled because adhesive from the labels migrated onto the label text, causing it to tear and become illegible when the label is peeled back. This recall includes various strengths and counts of Advil (ibuprofen) Tablets, Advil Liqui-Gels, and Advil Liqui-Gels (minis). To date, no incidents or injuries have been reported related to this issue. Consumers should contact their healthcare provider or pharmacist if they have concerns or questions about the medication.
Illegible labels may prevent consumers from reading critical dosage instructions, warnings, and expiration dates, potentially leading to incorrect or unsafe use of the medication.
You have 2 options:
Adhesive migration onto a portion of the label causing tearing.
Adhesive migration onto a portion of the label causing tearing.
Distributed by Pfizer, Madison, NJ.
Adhesive migration onto a portion of the label causing tearing.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.